Trial Profile
Linagliptin study of effects on PPG, postprandial blood glucose control
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Nov 2018
Price :
$35
*
At a glance
- Drugs Linagliptin (Primary) ; Voglibose
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms L-STEP
- 24 Jun 2015 Status changed from recruiting to completed as reported University Hospital Medical Information Network - Japan.
- 02 Aug 2012 New trial record